[ET Net News Agency, 24 June 2025] LUYE PHARMA (02186) rose 8.9% to HK$3.66.
It hits an intra-day high of HK$3.7, breaking above the 10-D SMA of HK$3.561, and an intra-day low of HK$3.34. The total shares traded was 76.34 million, with a value of HK$266.13m. The active buy/sell ratio is 68:32, with net buying turnover of HK$89.8m. CITIGROUP GLOBAL accounts for greatest net responsive buying turnover of HK$4.38m, with volume weighted average price of HK$3.511. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$10.82m, with volume weighted average price of HK$3.485. The stock has risen a combined 12.3% over the past 3 consecutive trading days.
Basic Information| Nominal | 3.660 | % Chg | +8.93% |
| High | 3.700 | Low | 3.340 |
| Shares Tr | 76.34m | Turnover | 266.13m |
| 10-D SMA | 3.561 | %H.V | 80.390 |
| 20-D SMA | 3.154 | VWAP | 3.486 |
| 50-D SMA | 2.457 | RSI14 | 69.056 |
Status: Breaking above the 10-D SMA, active buy/sell ratio is 68:32, with net buying turnover of HK$89.8m, rising a combined 12.3% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| LUYE PHARMA (02186) | 3.66 | +8.93 |
| SIHUAN PHARM (00460) | 1.14 | +4.59 |
| GRAND PHARMA (00512) | 8.69 | +1.40 |
| SINO BIOPHARM (01177) | 5.26 | +1.94 |
| HENGRUI PHARMA (01276) | 56.95 | +1.97 |
| LIVZON PHARMA (01513) | 29.05 | +1.04 |
| FOSUN PHARMA (02196) | 16.26 | +2.14 |
| SH PHARMA (02607) | 11.72 | +1.21 |
| CHINARES PHARMA (03320) | 5.20 | +0.97 |
| HANSOH PHARMA (03692) | 29.50 | +3.15 |
(ed)
Nominal 